lets find

another link

Thursday, 9 July 2009

[detikinet] Fwd: Cyber crime



Ini dari Eyang

---------- Forwarded message ----------
From: Eyang Yut <sologarut@yahoo.com>
Date: 2009/7/10
Subject: Re: Cyber crime
To: "~::asopans::~" <asopans@gmail.com>

Dear All
Menanggapi masalah Trafik Milis Berkurang, menurut saya berkat milling
list ini subscriber jadi pandai2 sehingga tak pernah posting tak
pernah bertanya masalahnya.
Soal tulisan yang berbobot sudah jarang itu juga kesalahan kita semua
terutama para Pendekar Dunia Maya kok nggak memposting disini, hanya
di blog spotnya saja.
Saran saya disamping posting di Blog Spot, kirim juga di milling list ini.
Meskipun saya lama nggak posting tapi saya selalu membaca yang rekan2
tulis, dan itu menanbah wawasan saya.

Sambil menyelam minum air, kali ini saya mohon bantuan milliser semua
yang saya anggap merupakan narasumber di Dunia Maya.
Masalahnya salah seorang rekan saya saat ini sedang dihadapkan pada
problema yang diluar kemampuan dan akal sehatnya, karena Situs
resminya di cloning dan diiklankan oleh orang yang tak bertanggung
jawab, sudah ada unsur2 cyber crime dan pelanggaran etika bisnis.

Singgih Susilo Kartono Siapa ya yang tinggal di Medan? bisa mohon
informasi alamat ini ada nggak ya PT. Magno Radio Taruma, Jl. Sei Kera
No. 12A, Medan, SUMUT, Indonesia 20124. Perusahaan ini telah membuat
web http://magno.en.ecplaza.net/ yang menjual produk Magno Radio
dengan mengambil gambar dan teks dari website saya. Saya juga
menemukan web yang hampir sama di
http://www.alibaba.com/member/id106111125.html
PT. Magno Radio Taruma - Magno Radio - EC Plaza
Sumber: magno.en.ecplaza.net
During my final years at university, I was troubled by a very big
question: Where should I go and what should I do after I graduate?
Should I work as an in-house designer, for a design office, somewhere
in the city or should I go back to my village.

Situs rekan saya yang asli adalah  http://www.magno-design.com/

Karena saya awam di Belantara Dunia Maya, saya tunggu sumbang saran /
pencerahan / arahan untuk mengungkap si pelaku dan diserahkan ke
Pengadilan untuk mempertanggung jawabkan segala perbuatannya

Wassalam

Soegini

________________________________
From: ~::asopans::~ <asopans@gmail.com>
To: Eyang Yut <sologarut@yahoo.com>
Sent: Friday, July 10, 2009 11:04:57 AM
Subject: Re: Cyber crime

Dear Eyang

Giaman kabar neh ?

Eyang, coba diposting sekali lagi sepertinya pas bukan sy yg moderasi,
klo pas sy email dari Eyang pasti sy lolosin

wassalam
Pakesu

2009/7/10 Eyang Yut <sologarut@yahoo.com>:
> Dear Ketua Suku
> Dak tunggu2 posting Eyang Yut tentang Cyber crime koq nggak nongol2.
> Apa ini termasuk SARA? Apa ada pertimbangan lain?
> Saya hanya ingin tahu bgmn caranya melacak hal2 yang berbau kejahatan tsb
> untuk membantu rekan yang betul2 jadi korban.
> Wassalam
> Eyang Yut
> Soegini
>

__._,_.___
Milistorial (NEW!) :

detikINET Forum: dari soal ponsel hingga komputer, olah digital hingga barter gambar, layanan internet hingga curhat pelanggan selular, dunia game hingga aktifitas underground, serta jual-beli dan lowongan kerja...

Kunjungi http://forum.detikinet.com detik ini juga!
Recent Activity
Visit Your Group
New business?

Get new customers.

List your web site

in Yahoo! Search.

Yahoo! Groups

Mental Health Zone

Learn about issues

Find support

Yahoo! Groups

Small Business Group

Ask questions,

share experiences

.

__,_._,___

[PozHealth] High CPK with Isentress





A few of us have had increased CPK with raltegravir.  To read about CPK:http://en.wikipedia.org/wiki/Creatine_kinase 
Has anyone seen this?

Exercising can cause transient increases.  I wonder if raltegravir can have long term consequences in some of us when it comes to muscle dystrophy problems...only time will tell.

Here is a report:

However, three laboratory adverse events were reported more frequently in patients in the raltegravir groups compared to patients in the placebo groups: elevations of ALT (4.5% vs 2.1%); elevations of AST (4.3% vs 2.5%); elevations of creatine phosphokinase (CPK) (3.2% vs 0.7%). As regards the aminotransferase elevations, they were usually transient and did not generally lead to study or drug discontinuation. In patients with hepatitis B and/or C co-infection, increases in ALT and AST did not differ between raltegravir and placebo groups: 5.1% and 7.7%, respectively, for the raltegravir group and 5.1% and 5.1%, respectively, for the placebo group. As regards the elevations of creatine phosphokinase, many of these elevations were transient and some were thought to be related to physical exercise. No patient discontinued therapy due to increased CPK.

__._,_.___
Welcome to our PozHealth group!

If you received this email from someone who forwarded it to you and would like to join this group, send a blank email to PozHealth-subscribe@yahoogroups.com and you will get an email with instructions to follow.

You can chose to receive single emails or a daily digest (collection of emails). You can post pictures, images, attach files and search by keyword old postings in the group.

For those of you who are members already and want to switch from single emails to digest or vice versa, visit www.yahoogroups.com, click on PozHealth, then on "edit my membership" and go down to your selection. The list administrator does not process any requests, so this is a do-it-yourself easy process ! :)

Thanks for joining. You will learn and share a lot in this group!

NOTE: I moderate, approve or disapprove emails before they are posted. Please follow the guidelines shown in the homepage. I will not allow rudeness, sexually  explicit material, attacks, and anyone who does not follow the rules. If you are not OK with this, please do not join the group.

Forward this email to anyone who may benefit from this information! Thanks!

In Health,

Nelson Vergel (PoWeRTX@aol.com)
List Founder and Moderator
Recent Activity
Visit Your Group
Give Back

Yahoo! for Good

Get inspired

by a good cause.

Y! Toolbar

Get it Free!

easy 1-click access

to your groups.

Yahoo! Groups

Start a group

in 3 easy steps.

Connect with others.

.

__,_._,___